Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Active Biotech AB

Headquarters: Lund, Sweden
Year Founded: 1996
Status: Public
Industry Sector: HealthTechnology
CEO: Helén Tuvesson, PhD
Number Of Employees: 6
Enterprise Value: $1,959,709
PE Ratio: -1.35
Exchange/Ticker 1: SSE:ACTI
Exchange/Ticker 2: N/A
Latest Market Cap: $9,022,550

BioCentury | Aug 10, 2018
Clinical News

Active, Teva's laquinimod misses in Phase II for HD

BioCentury | Jan 9, 2018
Finance

Stars in China

Biotech winners, losers in 4Q17
BioCentury | Jul 14, 2017
Strategy

Back to Ipsen’s roots

Why Ipsen is revving up clinical-stage BD and adding a venture fund
BioCentury | Jul 7, 2017
Finance

Onward and upward

Biotech winners, losers in 2Q17
BioCentury | Jun 21, 2017
Company News

Management tracks

BioCentury | Jun 7, 2017
Distillery Therapeutics

Cardiovascular; hematology

BioCentury | May 12, 2017
Clinical News

Teva's laquinimod fails Phase III RRMS trial

BioCentury | May 5, 2017
Clinical News

Teva's laquinimod fails Phase III RRMS study

Items per page:
1 - 10 of 249
Help Center
Username
Request a Demo
Request Training
Ask a Question